Exact Mass: 691.5209167999999

Exact Mass Matches: 691.5209167999999

Found 194 metabolites which its exact mass value is equals to given mass value 691.5209167999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PE(16:0/16:0)

(2-aminoethoxy)[(2R)-2,3-bis(hexadecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE(16:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/16:0), in particular, consists of two chains of palmitic acid at the C-1 and C-2 positions. The palmitic acid moieties are derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/16:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PE(16:0/16:0), in particular, consists of two hexadecanoyl chains at positions C-1 and C-2. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

PC(14:0/15:0)

trimethyl(2-{[(2R)-2-(pentadecanoyloxy)-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C37H74NO8P (691.5151774)


PC(14:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/15:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/22:3(6Z,9Z,12Z)) is a phosphatidylchloline (PC). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylcholines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PC(16:1(9Z)/22:3(6Z,9Z,12Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one 6Z,9Z,12Z-docosenoyl to the C-2 atom. In E. coli, PCs can be found in the integral component of the cell outer membrane. They are hydrolyzed by Phospholipases to a 2-acylglycerophosphocholine and a carboxylate.

   

PC(15:0/14:0)

trimethyl(2-{[(2R)-3-(pentadecanoyloxy)-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C37H74NO8P (691.5151774)


PC(15:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/14:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:2(9Z,11Z)/22:1(9Z)) is a phosphatidylchloline (PC). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylcholines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PC(16:2(9Z,11Z)/22:1(9Z)), in particular, consists of one 9Z,11Z-hexadecenoyl chain to the C-1 atom, and one 9Z-docosenoyl to the C-2 atom. In E. coli, PCs can be found in the integral component of the cell outer membrane. They are hydrolyzed by Phospholipases to a 2-acylglycerophosphocholine and a carboxylate.

   

PE(14:0/18:0)

(2-aminoethoxy)[(2R)-2-(octadecanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE(14:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/18:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of stearic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(14:0/18:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(14:0/18:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(18:0/14:0)

(2r)-3-{[(S)-(2-Aminoethoxy)(Hydroxy)phosphoryl]oxy}-2-(Tetradecanoyloxy)propyl Octadecanoate

C37H74NO8P (691.5151774)


PE(18:0/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/14:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:0/14:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:0/14:0), in particular, consists of one octadecanoyl chain to the C-1 atom, and one tetradecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

3-Sn-phosphatidylethanolamine

(2-aminoethoxy)[3-(octadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


3-Sn-phosphatidylethanolamine is a major structural phospholipid found in the brain, primarily in gray matter.

   

PE-NMe(15:0/16:0)

[2-(hexadecanoyloxy)-3-(pentadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE-NMe(15:0/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/16:0), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one hexadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:0/15:0)

[3-(hexadecanoyloxy)-2-(pentadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE-NMe(16:0/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/15:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(15:0/15:0)

[2,3-bis(pentadecanoyloxy)propoxy][2-(dimethylamino)ethoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE-NMe2(15:0/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(15:0/15:0), in particular, consists of two pentadecanoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(14:0/16:0)

[2-(dimethylamino)ethoxy][2-(hexadecanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE-NMe2(14:0/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(14:0/16:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one hexadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(16:0/14:0)

[2-(dimethylamino)ethoxy][3-(hexadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


PE-NMe2(16:0/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:0/14:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

1,2-Dipalmitoyl-rac-glycero-3-phosphoethanolamine

(2-aminoethoxy)[2,3-bis(hexadecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


   

Pallidol 3-O-glucoside

(2-{[(2R)-2-(decanoyloxy)-3-(nonadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C37H74NO8P (691.5151774)


   

Panaxydiol

(2-{[(2R)-3-(icosanoyloxy)-2-(nonanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C37H74NO8P (691.5151774)


   

Parthenocissin A

(2-{[(2R)-2-(henicosanoyloxy)-3-(octanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C37H74NO8P (691.5151774)


   

Phosphatidylethanolamine 16:0-16:0

Phosphatidylethanolamine 16:0-16:0

C37H74NO8P (691.5151774)


   

PE 32:0

Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C37H74NO8P (691.5151774)


Found in mouse spleen; TwoDicalId=317; MgfFile=160729_spleen_AA_16_Neg; MgfId=1135

   

16:0 PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine)

16:0 PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine)

C37H74NO8P (691.5151774)


   

1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine

(2-aminoethoxy)[2.3-bis(hexadecanoyloxy)propoxy]phosphinic acid

C37H74NO8P (691.5151774)


   

DIPALMITOYLPHOSPHATIDYLETHANOLAMINE

DIPALMITOYLPHOSPHATIDYLETHANOLAMINE

C37H74NO8P (691.5151774)


   

PC(13:0/16:0)[U]

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide

C37H74NO8P (691.5151774)


   

PC(14:0/15:0)[U]

3,5,8-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide

C37H74NO8P (691.5151774)


   

PC(15:0/14:0)[U]

3,5,9-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide

C37H74NO8P (691.5151774)


   

PC(16:0/13:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide

C37H74NO8P (691.5151774)


   

PC(18:0/11:0)[U]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide

C37H74NO8P (691.5151774)


   

PC(19:0/10:0)

3,5,9-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxodecyl)oxy]-, inner salt, 4-oxide, (R)-

C37H74NO8P (691.5151774)


   

PC(20:0/9:0)

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxononyl)oxy]-, inner salt, 4-oxide, (R)-

C37H74NO8P (691.5151774)


   

PC(8:0/21:0)

3,5,8-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxooctyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C37H74NO8P (691.5151774)


   

PC(9:0/20:0)

3,5,8-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxononyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C37H74NO8P (691.5151774)


   

PE(16:0/16:0)[U]

Ethanol, 2-amino-, dihydrogen phosphate (ester), monoester with 1,2-dipalmitin, DL-

C37H74NO8P (691.5151774)


   

PE(18:0/14:0)[U]

Octadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxotetradecyl)oxy]propyl ester

C37H74NO8P (691.5151774)


   

PE(16:0/16:0)

1,2-Dihexadecanoyl-sn-glycerol-3-phosphorylethanolamine

C37H74NO8P (691.5151774)


   

PE(12:0/20:0)[U]

1-dodecanoyl-2-eicosanoyl-sn-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(13:0/19:0)[U]

1-tridecanoyl-2-nonadecanoyl-sn-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(17:0/15:0)[U]

1-heptadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

Lecithin

1-pentadecanoyl-2-myristoyl-sn-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

PE(32:0)

1-Stearoyl-2-myristoyl-sn-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PC(12:0/17:0)

1-dodecanoyl-2-heptadecanoyl-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

PC(13:0/16:0)

1-tridecanoyl-2-hexadecanoyl-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

PC(16:0/13:0)

1-hexadecanoyl-2-tridecanoyl-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

PC(17:0/12:0)

1-heptadecanoyl-2-dodecanoyl-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

PE(20:0/12:0)

1-eicosanoyl-2-dodecanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(19:0/13:0)

1-nonadecanoyl-2-tridecanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(17:0/15:0)

1-heptadecanoyl-2-pentadecanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(15:0/17:0)

1-pentadecanoyl-2-heptadecanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(13:0/19:0)

1-tridecanoyl-2-nonadecanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PE(12:0/20:0)

1-dodecanoyl-2-eicosanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

PC 29:0

1-tetradecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

Barium arsenate

Barium arsenate

As2Ba3O8 (691.51822)


   

1,3-Dipalmitoyl-glycero-2-phosphoethanolamine

1,3-Dipalmitoyl-glycero-2-phosphoethanolamine

C37H74NO8P (691.5151774)


   

2-Ammonioethyl (2R)-2,3-bis(palmitoyloxy)propyl phosphate

2-Ammonioethyl (2R)-2,3-bis(palmitoyloxy)propyl phosphate

C37H74NO8P (691.5151774)


   

N,1-dipalmitoyl-sn-glycero-3-phosphoethanolamine

N,1-dipalmitoyl-sn-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

(2-Octadecanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Octadecanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]heptadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]heptadeca-4,8-diene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tricosane-1-sulfonic acid

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tricosane-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxynonadecane-1-sulfonic acid

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxynonadecane-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]henicos-4-ene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxypentadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxypentadeca-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxynonadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxynonadeca-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]henicosa-4,8-diene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxypentadec-4-ene-1-sulfonic acid

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxypentadec-4-ene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]heptadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]heptadeca-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]heptadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]heptadec-4-ene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxypentadecane-1-sulfonic acid

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxypentadecane-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]tricos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]tricos-4-ene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxypentadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxypentadeca-4,8-diene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxynonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxynonadeca-4,8-diene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]tricosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]tricosa-4,8-diene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]heptadecane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]heptadecane-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tricosa-4,8,12-triene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]henicosane-1-sulfonic acid

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]henicosane-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxynonadec-4-ene-1-sulfonic acid

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxynonadec-4-ene-1-sulfonic acid

C41H73NO5S (691.5209167999999)


   

2-[4-[10,13-dimethyl-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[10,13-dimethyl-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C44H69NO5 (691.5175463999999)


   
   
   
   
   
   
   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] tricosanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] icosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] icosanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] nonadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] nonadecanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] octadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] octadecanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] heptadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] heptadecanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] docosanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] henicosanoate

C37H74NO8P (691.5151774)


   

(3-Dodecanoyloxy-2-heptadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecanoyloxy-2-heptadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(2-Hexadecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexadecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(2-Pentadecanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Pentadecanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] tetracosanoate

C37H74NO8P (691.5151774)


   

(3-Acetyloxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Acetyloxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(3-Hexanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Hexanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] pentacosanoate

C37H74NO8P (691.5151774)


   

(3-Pentanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Pentanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(3-Butanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(2-Hexacosanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexacosanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] hexacosanoate

C37H74NO8P (691.5151774)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] heptacosanoate

C37H74NO8P (691.5151774)


   

(3-Decanoyloxy-2-nonadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-nonadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(2-Icosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Icosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(2-Henicosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Henicosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

(2-Docosanoyloxy-3-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Docosanoyloxy-3-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] docosanoate

C37H74NO8P (691.5151774)


   

[(2R)-2-octadecanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-octadecanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[(2S)-2-dodecanoyloxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-dodecanoyloxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] icosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] icosanoate

C37H74NO8P (691.5151774)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] henicosanoate

C37H74NO8P (691.5151774)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] docosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] docosanoate

C37H74NO8P (691.5151774)


   

[(2S)-3-octadecanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-octadecanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H74NO8P (691.5151774)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] henicosanoate

C37H74NO8P (691.5151774)


   

1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine

1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are both specified as hexadecanoyl (palmitoyl).

   

1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion

1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion

C37H74NO8P (691.5151774)


A phosphatidylethanolamine 32:0 zwitterion obtained by transfer of a proton from the phosphate to the amino group of 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine.

   

(2r)-3-{[(S)-(2-Aminoethoxy)(Hydroxy)phosphoryl]oxy}-2-(Tetradecanoyloxy)propyl Octadecanoate

(2r)-3-{[(S)-(2-Aminoethoxy)(Hydroxy)phosphoryl]oxy}-2-(Tetradecanoyloxy)propyl Octadecanoate

C37H74NO8P (691.5151774)


   

1-tetradecanoyl-2-octadecanoyl-glycero-3-phosphoethanolamine

1-tetradecanoyl-2-octadecanoyl-glycero-3-phosphoethanolamine

C37H74NO8P (691.5151774)


   

1-tetradecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

1-tetradecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


A phosphatidylcholine 29:0 in which the fatty acyl groups at positions 1 and 2 are specified as tetradecanoyl and pentadecanoyl respectively

   

1-pentadecanoyl-2-tetradecanoyl-glycero-3-phosphocholine

1-pentadecanoyl-2-tetradecanoyl-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

1-decanoyl-2-nonadecanoyl-sn-glycero-3-phosphocholine

1-decanoyl-2-nonadecanoyl-sn-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

phosphatidylethanolamine 32:0

phosphatidylethanolamine 32:0

C37H74NO8P (691.5151774)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 0 double bonds.

   

phosphatidylcholine 29:0

phosphatidylcholine 29:0

C37H74NO8P (691.5151774)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and contain a total of 29 carbons and no double bonds.

   

MePC(28:0)

MePC(16:0_12:0)

C37H74NO8P (691.5151774)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(30:0)

dMePE(16:0_14:0)

C37H74NO8P (691.5151774)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

BisMePE(30:0)

BisMePE(16:0_14:0)

C37H74NO8P (691.5151774)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

CerP(37:1)

CerP(t18:1_19:0(1+O))

C37H74NO8P (691.5151774)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved